Amgen stock gains as William Blair reiterates Outperform on positive cancer trial

Related
Apple places supply chain strategist in chief operating offi...
6 minutes ago
0
Mobileye Q2 guidance range above consensus
9 minutes ago
0
Toll Brothers partners with International Capital to develop...
24 minutes ago
0
Brookfield set to take 20% stake in U.K. Sizewell C nuclear ...
27 minutes ago
0
Voya sees Q2 alternative investment income near long-term ex...
29 minutes ago
0
UK carrier Virgin Atlantic strikes deal with Musk's Starlink...
34 minutes ago
0
RxSight stock slides on lower Q2 revenue guidance
37 minutes ago
0
Penguin Solutions Non-GAAP EPS of $0.47 beats by $0.15, reve...
38 minutes ago
0
Granite awarded $111M Utah DOT project in Salt Lake City
41 minutes ago
0
Nasdaq's U.S. matched equity volume edges up in June
43 minutes ago
0
Cogent Biosciences announces $150M public offering of common...
45 minutes ago
0
Kura Sushi gains after posting an unexpected FQ3 profit
48 minutes ago
0
Presidio Property Trust 9.375% Preferred Series D declares $...
55 minutes ago
0
Trump doubles down on his Aug. 1 tariff deadline as stocks c...
57 minutes ago
0
Amazon’s tariff-clouded, seller-confused, AI-researched, wei...
58 minutes ago
0
Ellington Financial declares $0.13 dividend
59 minutes ago
0
Procter & Gamble declares $1.0568 dividend
1 hour ago
0